Areas of Interest

We build on our internal expertise, transforming breakthrough science into effective medicine.

Our Key Focus Areas


As leading experts in autoimmune diseases and therapies, we are focused on developing new medicines to address chronic progressive diseases in the field of immunology. Our programs focus on investigating both targeted oral therapies and biologics. Our areas of interest include:

  • Rheumatoid arthritis (RA)
  • Inflammatory bowel disease (IBD)
  • Psoriasis and dermatologic diseases
  • Psoriatic arthritis (PsA)
  • Osteoarthritis (OA)
  • Systemic lupus erythematosis


Our research is committed to discovering and developing targeted therapies that work against the processes cancer cells need to survive. We are investigating both small and large molecule approaches, and our internal research efforts are balanced with external collaborations across industry, academia and health care authorities. Our areas of interest include:

  • Solid tumors
  • Hematologic malignancies
  • Next-generation immuno-oncology


Our innovative research focuses on developing therapies for neurodegenerative diseases by targeting mechanisms that block neurodegeneration and promote neuroprotection and regeneration. We are interested in highly validated targets and biomarkers. Our areas of interest include:

  • Alzheimer’s disease
  • Multiple sclerosis
  • Parkinson’s disease


Our hepatology franchise is anchored with our antiviral program targeting hepatitis C virus. We are looking to expand our presence in the area by targeting nonalcoholic steatohepatitis (NASH) and other fibrotic liver diseases.

Additional focus areas

We also focus our attention on other areas where there is unmet need, including:

  • Cystic fibrosis
  • New formulations
  • Discovery and development platforms & technologies

For more information about partnering with AbbVie, download our brochure.